Recon: AbbVie, Boehringer Settle Humira Patent Dispute - Regulatory ...
05/14/19
Recon: AbbVie, Boehringer Settle Humira Patent Dispute Regulatory Focus
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. AbbVie, Boehringer Settle US Patent Dispute Over ...
[more]